Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspective

Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces

Author(s): Federico Perosa*, Elvira Favoino and Marcella Prete

Volume 21, Issue 4, 2021

Published on: 07 December, 2020

Page: [567 - 568] Pages: 2

DOI: 10.2174/1871530320666201207234914

Next »
[1]
Zhou, P.; Yang, X.L.; Wang, X.G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.R.; Zhu, Y.; Li, B.; Huang, C.L.; Chen, H.D.; Chen, J.; Luo, Y.; Guo, H.; Jiang, R.D.; Liu, M.Q.; Chen, Y.; Shen, X.R.; Wang, X.; Zheng, X.S.; Zhao, K.; Chen, Q.J.; Deng, F.; Liu, L.L.; Yan, B.; Zhan, F.X.; Wang, Y.Y.; Xiao, G.F.; Shi, Z.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, 579(7798), 270-273.
[http://dx.doi.org/10.1038/s41586-020-2012-7]]
[2]
Roper, R.L.; Rehm, K.E. SARS vaccines: where are we? Expert Rev. Vaccines, 2009, 8(7), 887-898.
[http://dx.doi.org/10.1586/erv.09.43] [PMID: 19538115]
[3]
Gao, W.; Tamin, A.; Soloff, A.; D’Aiuto, L.; Nwanegbo, E.; Robbins, P.D.; Bellini, W.J.; Barratt-Boyes, S.; Gambotto, A. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet, 2003, 362(9399), 1895-1896.
[http://dx.doi.org/10.1016/S0140-6736(03)14962-8]]
[4]
Bukreyev, A.; Lamirande, E.W.; Buchholz, U.J.; Vogel, L.N.; Elkins, W.R.; St Claire, M.; Murphy, B.R.; Subbarao, K.; Collins, P.L. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet, 2004, 363(9427), 2122-2127.
[http://dx.doi.org/10.1016/S0140-6736(04)16501-X] [PMID: 15220033]
[5]
Lin, J.T.; Zhang, J.S.; Su, N. Xu, J.G.; Wang, N.; Chen, J.T.; Chen, X.; Liu, Y.X.; Gao, H.; Jia, Y.P.; Liu, Y.; Sun, R.H.; Wang, X.; Yu, D.Z.; Hai, R.; Gao, Q.; Ning, Y.; Wang, H.X.; Li, M.C.; Kan, B.; Dong, G.M.; An, Q.; Wang, Y.Q.; Han, J.; Qin, C.; Yin, W.D.; Dongs, X.P. Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine. Antivir. Ther., 2007, 12(7), 1107-1113.
[PMID: 18018769]
[6]
Andersen, K.G.; Rambaut, A.; Lipkin, W.I.; Holmes, E.C.; Garry, R.F. The proximal origin of SARS-CoV-2. Nat. Med., 2020, 26(4), 450-452.
[http://dx.doi.org/10.1038/s41591-020-0820-9] [PMID: 32284615]
[7]
Prete, M.; Favoino, E.; Catacchio, G.; Racanelli, V.; Perosa, F. SARS-CoV-2 inflammatory syndrome. Clinical features and rationale for immunological treatment. Int. J. Mol. Sci., 2020, 21(9), 3377.
[http://dx.doi.org/10.3390/ijms21093377] [PMID: 32397684]
[8]
Prete, M.; Favoino, E.; Catacchio, G.; Racanelli, V.; Perosa, F. SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? Autoimmun. Rev., 2020, 19(7)102559
[http://dx.doi.org/10.1016/j.autrev.2020.102559] [PMID: 32361195]
[9]
Das, S.; Das, S.; Ghangrekar, M.M. The COVID-19 pandemic: biological evolution, treatment options and consequences. Innov. Infrastruct. Solut., 2020, 5(3)76.10.1007/s41062-020-00325-8

Rights & Permissions Print Cite
Article Metrics
14
1
© 2024 Bentham Science Publishers | Privacy Policy